Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Deborah Schrag, MD, MPH


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Chief, Division of Population Sciences, Department of Medical Oncology
  • Senior Physician
  • Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • Gastrointestinal cancers

Contact Information

  • Appointments617-632-5929
  • Office Phone Number617-582-8301
  • Fax617-582-7450

Bio

Dr. Schrag received her medical degree from Columbia University in New York in 1991. She subsequently completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 1998, and joined the staff of DFCI and Brigham and Women's Hospital. From 1999 through 2007, Dr. Schrag practiced medical oncology in the Division of Gastrointestinal Oncology at Memorial Sloan-Kettering Cancer Center, where she was an Associate Member and Associate Professor of Public Health and Medicine. In 2007, she returned to DFCI and Brigham and Womens Hospital, where she is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. Her research focuses on utilization of new cancer treatment technologies at the population level.

Board Certification:

  • Internal Medicine
  • Medical Oncology

Fellowship:

  • Dana-Farber Cancer Institute, Medical Oncology

Residency:

  • Brigham and Women's Hospital, Internal Medicine

Medical School:

  • Columbia University

Research

Racial Disparities in Colorectal Cancer Recurrence and Mortality: Equitable Care, Inequitable Outcomes? J Natl Cancer Inst. 2021 Jun 01; 113(6):656-657.
View in: PubMed

Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021 02 16; 325(7):669-685.
View in: PubMed

Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial. Cancers (Basel). 2020 Nov 20; 12(11).
View in: PubMed

The Effect of Disclosing Life Expectancy Information on Patients' Prognostic Understanding: Secondary Outcomes From a Multicenter Randomized Trial of a Palliative Chemotherapy Educational Intervention. J Pain Symptom Manage. 2021 01; 61(1):1-11.e3.
View in: PubMed

Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Oncol. 2020 08 01; 6(8):1265-1270.
View in: PubMed

Oncology Practice During the COVID-19 Pandemic. JAMA. 2020 May 26; 323(20):2005-2006.
View in: PubMed

Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era. Cancer Med. 2020 03; 9(6):2019-2029.
View in: PubMed

Adding Patient-Reported Outcomes to Medicare's Oncology Value-Based Payment Model. JAMA. 2020 01 21; 323(3):213-214.
View in: PubMed

Insurance Networks and Access to Affordable Cancer Care. J Clin Oncol. 2020 02 01; 38(4):310-315.
View in: PubMed

Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set. JCO Clin Cancer Inform. 2019 08; 3:1-13.
View in: PubMed

Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019 04 09; 321(14):1370-1379.
View in: PubMed

Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data. JCO Clin Cancer Inform. 2019 04; 3:1-10.
View in: PubMed

Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Am Med Inform Assoc. 2019 04 01; 26(4):276-285.
View in: PubMed

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer. J Natl Cancer Inst. 2019 04 01; 111(4):431-434.
View in: PubMed

FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial. Cancer. 2019 07 01; 125(13):2213-2221.
View in: PubMed

Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer. Cancer Immunol Immunother. 2019 Jun; 68(6):917-926.
View in: PubMed

Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance). Clin Trials. 2019 04; 16(2):165-175.
View in: PubMed

Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Oncologist. 2019 07; 24(7):945-954.
View in: PubMed

Oncology in Transition: Changes, Challenges, and Opportunities. JAMA. 2018 12 04; 320(21):2203-2204.
View in: PubMed

Assessment of Between-Hospital Variation in Readmission and Mortality After Cancer Surgical Procedures. JAMA Netw Open. 2018 10 05; 1(6):e183038.
View in: PubMed

Survival Disparities by Race and Ethnicity in Early Esophageal Cancer. Dig Dis Sci. 2018 11; 63(11):2880-2888.
View in: PubMed

Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR Hum Factors. 2018 Jul 16; 5(3):e10070.
View in: PubMed

Factors Contributing To Geographic Variation In End-Of-Life Expenditures For Cancer Patients. Health Aff (Millwood). 2018 07; 37(7):1136-1143.
View in: PubMed

Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA. 2018 05 22; 319(20):2104-2115.
View in: PubMed

Lack of Association Between Heart Failure and Incident Cancer. J Am Coll Cardiol. 2018 04 10; 71(14):1501-1510.
View in: PubMed

Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018 04; 16(4):387-394.
View in: PubMed

Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018 02; 7(2):525-535.
View in: PubMed

Diffusion of Bevacizumab Across Oncology Practices: An Observational Study. Med Care. 2018 01; 56(1):69-77.
View in: PubMed

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers. Adv Radiat Oncol. 2018 Jan-Mar; 3(1):34-41.
View in: PubMed

Evaluation of Patient and Family Outpatient Complaints as a Strategy to Prioritize Efforts to Improve Cancer Care Delivery. Jt Comm J Qual Patient Saf. 2017 Oct; 43(10):498-507.
View in: PubMed

Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter? Health Serv Res. 2018 08; 53 Suppl 1:3227-3244.
View in: PubMed

Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies. J Natl Cancer Inst. 2017 08 01; 109(8).
View in: PubMed

Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death. Health Serv Res. 2018 08; 53(4):2118-2132.
View in: PubMed

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017 07 11; 318(2):197-198.
View in: PubMed

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 2017 06 20; 317(23):2392-2401.
View in: PubMed

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Cancer. 2017 Sep 15; 123(18):3532-3539.
View in: PubMed

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol. 2017 Jul 01; 35(19):2165-2172.
View in: PubMed

Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. Oncologist. 2017 08; 22(8):925-933.
View in: PubMed

The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Am J Gastroenterol. 2017 Aug; 112(8):1256-1264.
View in: PubMed

A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy. Patient Educ Couns. 2017 Aug; 100(8):1527-1536.
View in: PubMed

Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263.
View in: PubMed

Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER-Medicare study. Gastric Cancer. 2017 Sep; 20(5):811-824.
View in: PubMed

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017 Apr 01; 35(10):1086-1095.
View in: PubMed

Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. JAMA Oncol. 2017 Jan 01; 3(1):101-104.
View in: PubMed

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy. J Natl Compr Canc Netw. 2016 12; 14(12):1528-1534.
View in: PubMed

Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma. J Neurooncol. 2017 01; 131(2):301-311.
View in: PubMed

Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients. Med Care. 2016 08; 54(8):e47-54.
View in: PubMed

Racial/Ethnic and Socioeconomic Differences in Colorectal and Breast Cancer Treatment Quality: The Role of Physician-level Variations in Care. Med Care. 2016 08; 54(8):780-8.
View in: PubMed

Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries. Breast Cancer Res Treat. 2016 08; 158(3):573-81.
View in: PubMed

Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research. J Natl Cancer Inst. 2016 12; 108(12).
View in: PubMed

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. J Clin Oncol. 2016 08 20; 34(24):2925-34.
View in: PubMed

Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision. JAMA. 2016 May 03; 315(17):1837-8.
View in: PubMed

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Health Qual Life Outcomes. 2016 Feb 19; 14:24.
View in: PubMed

Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be More. Am Soc Clin Oncol Educ Book. 2016; 35:92-102.
View in: PubMed

High Intensity of End-of-Life Care Among Adolescent and Young Adult Cancer Patients in the New York State Medicaid Program. Med Care. 2015 Dec; 53(12):1018-26.
View in: PubMed

Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis. J Palliat Med. 2016 Jan; 19(1):42-50.
View in: PubMed

Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment. Cancer. 2016 Feb 01; 122(3):420-31.
View in: PubMed

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9.
View in: PubMed

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol. 2015 Aug 10; 33(23):2563-77.
View in: PubMed

Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond. J Natl Cancer Inst. 2015 Mar 11; 107(5).
View in: PubMed

Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study. Med Decis Making. 2015 04; 35(3):371-87.
View in: PubMed

Locally advanced rectal cancer: time for precision therapeutics. Am Soc Clin Oncol Educ Book. 2015; e192-6.
View in: PubMed

Incidence of minimally invasive colorectal cancer surgery at National Comprehensive Cancer Network centers. J Natl Cancer Inst. 2015 Jan; 107(1):362.
View in: PubMed

Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer. J Thorac Oncol. 2014 Dec; 9(12):1788-95.
View in: PubMed

Evaluation of the duplication of staging CT scans for localized colon cancer in a Medicare population. Med Care. 2014 Nov; 52(11):963-8.
View in: PubMed

Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS). Leuk Res. 2014 Dec; 38(12):1420-4.
View in: PubMed

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep; 106(9).
View in: PubMed

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer. J Natl Cancer Inst. 2014 Oct; 106(10).
View in: PubMed

Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer. J Natl Compr Canc Netw. 2014 Aug; 12(8):1123-30.
View in: PubMed

Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage. Ann Epidemiol. 2014 Sep; 24(9):666-72, 672.e1-2.
View in: PubMed

Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. J Oncol Pract. 2014 Sep; 10(5):e360-7.
View in: PubMed

Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study. Ann Intern Med. 2014 Jul 01; 161(1):20-30.
View in: PubMed

Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2014 Nov; 21(12):3766-73.
View in: PubMed

Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist. 2014 Jun; 19(6):637-8.
View in: PubMed

Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014 May; 10(3):162-7.
View in: PubMed

Hospitalization burden and survival among older glioblastoma patients. Neuro Oncol. 2014 Nov; 16(11):1530-40.
View in: PubMed

Hospital variation in sphincter preservation for elderly rectal cancer patients. J Surg Res. 2014 Sep; 191(1):161-8.
View in: PubMed

Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2014 Feb; 106(2):djt371.
View in: PubMed

Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions. J Natl Compr Canc Netw. 2014 Feb; 12(2):235-43.
View in: PubMed

Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol. 2014 Feb 20; 32(6):513-8.
View in: PubMed

Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014 Feb 20; 32(6):496-503.
View in: PubMed

National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010. Cancer. 2014 Apr 01; 120(7):1050-8.
View in: PubMed

Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013 Dec 10; 31(35):4465-70.
View in: PubMed

Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst. 2013 Dec 04; 105(23):1806-13.
View in: PubMed

Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol. 2013 Nov 10; 31(32):4151-7.
View in: PubMed

What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups. Support Care Cancer. 2014 Jan; 22(1):233-44.
View in: PubMed

PS1-39: Diagnosis Codes for Cancer Metastasis on Medicare Claims Have Limited Accuracy and Completeness. Clin Med Res. 2013 Sep; 11(3):131.
View in: PubMed

Evolving role of neoadjuvant therapy in rectal cancer. Curr Treat Options Oncol. 2013 Sep; 14(3):350-64.
View in: PubMed

Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013 Dec; 20(13):4128-36.
View in: PubMed

Changes in the availability of screening mammography, 2000-2010. Cancer. 2013 Nov 01; 119(21):3847-53.
View in: PubMed

Reply to F. Fiorica et al and D. Vordermark. J Clin Oncol. 2013 Jul 20; 31(21):2759-60.
View in: PubMed

Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer. J Clin Oncol. 2013 Jul 20; 31(21):2730-5.
View in: PubMed

Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013 Jul 10; 31(20):2580-5.
View in: PubMed

Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol. 2013 Jul 10; 31(20):2569-79.
View in: PubMed

Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst. 2013 Jun 05; 105(11):774-81.
View in: PubMed

Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancer. Oncologist. 2013; 18(4):377-8.
View in: PubMed

Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer. Cancer. 2013 Jun 01; 119(11):2048-60.
View in: PubMed

Regional variation in spending and survival for older adults with advanced cancer. J Natl Cancer Inst. 2013 May 01; 105(9):634-42.
View in: PubMed

Changes in access to screening mammography, 2008-2011. Cancer Causes Control. 2013 May; 24(5):1057-9.
View in: PubMed

Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium. J Comp Eff Res. 2013 Mar; 2(2):117-25.
View in: PubMed

The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013; 18(4):381-90.
View in: PubMed

Talking with patients about dying. N Engl J Med. 2013 01 31; 368(5):480-1.
View in: PubMed

Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol. 2013 Feb 10; 31(5):558-64.
View in: PubMed

Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013; 18(1):64-72.
View in: PubMed

Do older Americans undergo stoma reversal following low anterior resection for rectal cancer? J Surg Res. 2013 Jul; 183(1):238-45.
View in: PubMed

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst. 2013 Jan 16; 105(2):85-94.
View in: PubMed

Measuring colorectal cancer care quality for the publicly insured in New York State. Cancer Med. 2012 Dec; 1(3):363-71.
View in: PubMed

Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. J Clin Oncol. 2013 Jan 01; 31(1):30-8.
View in: PubMed

Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions. Cancer. 2013 Mar 01; 119(5):1065-72.
View in: PubMed

Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med. 2012 Nov 06; 157(9):611-20.
View in: PubMed

Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012 Oct 25; 367(17):1616-25.
View in: PubMed

Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. Arch Surg. 2012 Aug; 147(8):715-23.
View in: PubMed

Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst. 2012 Jul 18; 104(14):1102-5.
View in: PubMed

Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer. PLoS One. 2012; 7(6):e38231.
View in: PubMed

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012 Jul 20; 30(21):2624-34.
View in: PubMed

The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients. Cancer. 2012 Nov 15; 118(22):5652-62.
View in: PubMed

Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA. 2012 Apr 18; 307(15):1593-601.
View in: PubMed

Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
View in: PubMed

Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer. 2012 Sep 01; 118(17):4309-20.
View in: PubMed

Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst. 2012 Feb 08; 104(3):211-27.
View in: PubMed

Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol. 2012 Feb 20; 30(6):608-15.
View in: PubMed

Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). J Pain Symptom Manage. 2012 Feb; 43(2):205-17.
View in: PubMed

Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol. 2011 Dec 20; 29(36):4796-802.
View in: PubMed

Mammography capacity and appointment wait times: barriers to breast cancer screening. Cancer Causes Control. 2012 Jan; 23(1):45-50.
View in: PubMed

Reliability of adverse symptom event reporting by clinicians. Qual Life Res. 2012 Sep; 21(7):1159-64.
View in: PubMed

Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer. 2011 Aug 16; 11:354.
View in: PubMed

American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol. 2011 Aug 20; 29(24):3328-30.
View in: PubMed

Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol. 2011 Aug 20; 29(24):3255-62.
View in: PubMed

Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011 Oct; 146(10):1128-34.
View in: PubMed

Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e197-206.
View in: PubMed

Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation. J Clin Oncol. 2011 Jun 10; 29(17):2305-11.
View in: PubMed

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer. 2011 Nov 15; 117(22):5094-102.
View in: PubMed

Racial variation in willingness to trade financial resources for life-prolonging cancer treatment. Cancer. 2011 Aug 01; 117(15):3476-84.
View in: PubMed

Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med. 2011 Mar; 1(1):110-22.
View in: PubMed

Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. Oncologist. 2011; 16(8):1082-91.
View in: PubMed

Building capacity to assess cancer care in the Medicaid population in New York State. Health Serv Res. 2011 Jun; 46(3):805-20.
View in: PubMed

Cancer screening among patients with advanced cancer. JAMA. 2010 Oct 13; 304(14):1584-91.
View in: PubMed

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol. 2010 Aug 01; 28(22):3617-22.
View in: PubMed

Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer. 2010 Jun 01; 116(11):2560-70.
View in: PubMed

Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? J Clin Oncol. 2010 Jul 10; 28(20):3207-10.
View in: PubMed

Geographic access and the use of screening mammography. Med Care. 2010 Apr; 48(4):349-56.
View in: PubMed

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA. 2010 Mar 17; 303(11):1037-45.
View in: PubMed

Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med. 2010 Mar 08; 170(5):440-50.
View in: PubMed

Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data. Appl Health Econ Health Policy. 2010; 8(1):37-51.
View in: PubMed

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009 Dec 02; 101(23):1624-32.
View in: PubMed

Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol. 2009 Dec 20; 27(36):6166-71.
View in: PubMed

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010 Jan 20; 28(3):493-508.
View in: PubMed

Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis. J Natl Compr Canc Netw. 2009 Sep; 7(8):895-904.
View in: PubMed

Centralization of cancer surgery: what does it mean for surgical training? J Clin Oncol. 2009 Oct 01; 27(28):4637-9.
View in: PubMed

Challenges and opportunities for use of cost-effectiveness analysis. J Natl Cancer Inst. 2009 Sep 02; 101(17):1161-3.
View in: PubMed

Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers. Ann Surg. 2009 Aug; 250(2):260-7.
View in: PubMed

American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009 Aug 10; 27(23):3868-74.
View in: PubMed

Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care. 2009 Jul; 47(7 Suppl 1):S64-9.
View in: PubMed

Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care. 2009 Jul; 47(7 Suppl 1):S56-63.
View in: PubMed

Rapidity and modality of imaging for acute low back pain in elderly patients. Arch Intern Med. 2009 May 25; 169(10):972-81.
View in: PubMed

Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors. Cancer Invest. 2009 May; 27(4):402-6.
View in: PubMed

Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer. JAMA. 2009 Mar 18; 301(11):1140-7.
View in: PubMed

Evaluating the impact of organizational changes in health care delivery: challenges in study design. J Clin Oncol. 2009 Apr 10; 27(11):1744-5.
View in: PubMed

A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. 2009; 12(4):233-44.
View in: PubMed

Primary care physicians' links to other physicians through Medicare patients: the scope of care coordination. Ann Intern Med. 2009 Feb 17; 150(4):236-42.
View in: PubMed

Linking tumor registry and Medicaid claims to evaluate cancer care delivery. Health Care Financ Rev. 2009; 30(4):61-73.
View in: PubMed

Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer. Invest New Drugs. 2009 Aug; 27(4):366-73.
View in: PubMed

American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol. 2008 Jul 20; 26(21):3631-7.
View in: PubMed

Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis. J Natl Cancer Inst. 2008 Jul 16; 100(14):1013-21.
View in: PubMed

Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008 Jul 01; 113(1):57-64.
View in: PubMed

Enhancing cancer registry data to promote rational health system design. J Natl Cancer Inst. 2008 Mar 19; 100(6):378-9.
View in: PubMed

How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008 Mar 10; 26(8):1364-70.
View in: PubMed

Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum. 2008 May; 51(5):503-7.
View in: PubMed

Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008 Jan 20; 26(3):380-5.
View in: PubMed

Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol. 2008 May; 53(5):960-6.
View in: PubMed

Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum. 2008 Feb; 51(2):147-53.
View in: PubMed

Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol. 2007 Dec 01; 25(34):5374-80.
View in: PubMed

Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol. 2007 Nov 20; 25(33):5275-80.
View in: PubMed

Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum. 2007 Sep; 50(9):1393-400.
View in: PubMed

Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1456-66.
View in: PubMed

The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007 Aug 01; 99(15):1171-7.
View in: PubMed

Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care. 2007 Jun; 45(6):562-70.
View in: PubMed

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007 Aug; 17(8):584-90.
View in: PubMed

Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Stat Med. 2007 Apr 30; 26(9):2017-35.
View in: PubMed

When you look matters: the effect of assessment schedule on progression-free survival. J Natl Cancer Inst. 2007 Mar 21; 99(6):428-32.
View in: PubMed

Care patterns in Medicare and their implications for pay for performance. N Engl J Med. 2007 Mar 15; 356(11):1130-9.
View in: PubMed

Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc. 2007 May-Jun; 14(3):264-8.
View in: PubMed

Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Ann Surg Oncol. 2007 May; 14(5):1727-34.
View in: PubMed

Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol. 2007 Jan 10; 25(2):233-7.
View in: PubMed

Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1204-11.
View in: PubMed

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006 Nov; 7(11):903-9.
View in: PubMed

How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006 Oct 01; 107(7):1624-33.
View in: PubMed

Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):492-9.
View in: PubMed

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol. 2006 Jun 20; 24(18):2757-64.
View in: PubMed

Fragmentation of care for frequently hospitalized urban residents. Med Care. 2006 Jun; 44(6):560-7.
View in: PubMed

Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 2):3601s-5s.
View in: PubMed

Using propensity scores to estimate the cost-effectiveness of medical therapies. Stat Med. 2006 May 15; 25(9):1561-76.
View in: PubMed

Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006 Mar 20; 24(9):1357-62.
View in: PubMed

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006 Feb 01; 98(3):172-80.
View in: PubMed

Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006 Feb 01; 98(3):163-71.
View in: PubMed

A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. . 2005 Dec 01; 40(4):451-5.
View in: PubMed

Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2005 Nov 16; 97(22):1705-6; author reply 1706-7.
View in: PubMed

Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma. Cancer. 2005 Nov 01; 104(9):1871-84.
View in: PubMed

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005 Oct 05; 97(19):1407-27.
View in: PubMed

The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer. 2005 Sep 15; 104(6):1149-57.
View in: PubMed

Communication and coordination: the keys to quality. J Clin Oncol. 2005 Sep 20; 23(27):6452-5.
View in: PubMed

Cetuximab therapy and symptomatic hypomagnesemia. J Natl Cancer Inst. 2005 Aug 17; 97(16):1221-4.
View in: PubMed

Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005 Aug 15; 104(4):848-55.
View in: PubMed

Delivery of preventive services to older adults by primary care physicians. JAMA. 2005 Jul 27; 294(4):473-81.
View in: PubMed

The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum. 2005 Jul; 48(7):1353-65.
View in: PubMed

Discussing drug costs with patients. Clin Adv Hematol Oncol. 2005 Jul; 3(7):525-6.
View in: PubMed

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Urology. 2005 Jun; 65(6):1118-25.
View in: PubMed

Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol. 2005 May 20; 23(15):3552-61.
View in: PubMed

An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer. J Clin Oncol. 2005 Mar 20; 23(9):1799-802.
View in: PubMed

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol. 2005 Mar 20; 23(9):1803-10.
View in: PubMed

Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA. 2004 Dec 08; 292(22):2765-70.
View in: PubMed

Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol. 2004 Sep 01; 22(17):3475-84.
View in: PubMed

Primary care physicians who treat blacks and whites. N Engl J Med. 2004 Aug 05; 351(6):575-84.
View in: PubMed

American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays. J Clin Oncol. 2004 Sep 01; 22(17):3631-8.
View in: PubMed

The price tag on progress--chemotherapy for colorectal cancer. N Engl J Med. 2004 Jul 22; 351(4):317-9.
View in: PubMed

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004 Aug 15; 22(16):3408-19.
View in: PubMed

Use of information resources by patients with cancer and their companions. Cancer. 2004 Jun 01; 100(11):2476-83.
View in: PubMed

Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. J Clin Oncol. 2004 Jan 01; 22(1):166-74.
View in: PubMed

The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004 Jan; 198(1):42-50.
View in: PubMed

The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med. 2003 Oct 21; 139(8):658-65.
View in: PubMed

Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med. 2003 Oct 21; 139(8):649-57.
View in: PubMed

Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol. 2003 Jun; 83(2):68-78; discussion 78-9.
View in: PubMed

Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst. 2003 Apr 16; 95(8):588-97.
View in: PubMed

Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg. 2002 Nov; 236(5):583-92.
View in: PubMed

Risk charts: putting cancer in context. J Natl Cancer Inst. 2002 Oct 16; 94(20):1584-5; author reply 1585-6.
View in: PubMed

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002 Oct 01; 20(19):3999-4005.
View in: PubMed

Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002 Aug; 40(8 Suppl):IV-19-25.
View in: PubMed

Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care. 2002 Aug; 40(8 Suppl):IV-96-103.
View in: PubMed

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002 Aug; 40(8 Suppl):IV-3-18.
View in: PubMed

Attribution of deaths following cancer treatment. J Natl Cancer Inst. 2002 Jul 17; 94(14):1044-5.
View in: PubMed

Survival of blacks and whites after a cancer diagnosis. JAMA. 2002 Apr 24; 287(16):2106-13.
View in: PubMed

Variations in morbidity after radical prostatectomy. N Engl J Med. 2002 Apr 11; 346(15):1138-44.
View in: PubMed

Decadal sea surface temperature variability in the subtropical South Pacific from 1726 to 1997 A.D. Science. 2000 Nov 10; 290(5494):1145-8.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Ratings

Top